| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-102 |
Sentence |
denotes |
Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. |
| T1 |
0-102 |
Sentence |
denotes |
Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. |
| T2 |
103-245 |
Sentence |
denotes |
Rett syndrome is a neurodevelopmental disorder, which occurs in about 1:15,000 females and presents with neurologic and communication defects. |
| T2 |
103-245 |
Sentence |
denotes |
Rett syndrome is a neurodevelopmental disorder, which occurs in about 1:15,000 females and presents with neurologic and communication defects. |
| T3 |
246-478 |
Sentence |
denotes |
It is transmitted as an X-linked dominant linked to mutations of the methyl-CpG-binding protein (MeCP2), a gene transcription suppressor, but its definitive pathogenesis is unknown thus hindering development of effective treatments. |
| T3 |
246-478 |
Sentence |
denotes |
It is transmitted as an X-linked dominant linked to mutations of the methyl-CpG-binding protein (MeCP2), a gene transcription suppressor, but its definitive pathogenesis is unknown thus hindering development of effective treatments. |
| T4 |
479-610 |
Sentence |
denotes |
Almost half of children with Rett syndrome also have behavioral symptoms consistent with those of autism spectrum disorders (ASDs). |
| T4 |
479-610 |
Sentence |
denotes |
Almost half of children with Rett syndrome also have behavioral symptoms consistent with those of autism spectrum disorders (ASDs). |
| T5 |
611-913 |
Sentence |
denotes |
PubMed was searched (2005-2014) using the terms: allergy, atopy, brain, brain-derived neurotrophic factor (BDNF), corticotropin-releasing hormone (CRH), cytokines, gene mutations, inflammation, mast cells (MCs), microglia, mitochondria, neurotensin (NT), neurotrophins, seizures, stress, and treatment. |
| T5 |
611-913 |
Sentence |
denotes |
PubMed was searched (2005-2014) using the terms: allergy, atopy, brain, brain-derived neurotrophic factor (BDNF), corticotropin-releasing hormone (CRH), cytokines, gene mutations, inflammation, mast cells (MCs), microglia, mitochondria, neurotensin (NT), neurotrophins, seizures, stress, and treatment. |
| T6 |
914-1007 |
Sentence |
denotes |
There are a number of intriguing differences and similarities between Rett syndrome and ASDs. |
| T6 |
914-1007 |
Sentence |
denotes |
There are a number of intriguing differences and similarities between Rett syndrome and ASDs. |
| T7 |
1008-1128 |
Sentence |
denotes |
Rett syndrome occurs in females, while ASDs more often in males, and the former has neurologic disabilities unlike ASDs. |
| T7 |
1008-1128 |
Sentence |
denotes |
Rett syndrome occurs in females, while ASDs more often in males, and the former has neurologic disabilities unlike ASDs. |
| T8 |
1129-1210 |
Sentence |
denotes |
There is evidence of dysregulated immune system early in life in both conditions. |
| T8 |
1129-1210 |
Sentence |
denotes |
There is evidence of dysregulated immune system early in life in both conditions. |
| T9 |
1211-1425 |
Sentence |
denotes |
Lack of microglial phagocytosis and decreased levels of BDNF appear to distinguish Rett syndrome from ASDs, in which there is instead microglia activation and/or proliferation and possibly defective BDNF signaling. |
| T9 |
1211-1425 |
Sentence |
denotes |
Lack of microglial phagocytosis and decreased levels of BDNF appear to distinguish Rett syndrome from ASDs, in which there is instead microglia activation and/or proliferation and possibly defective BDNF signaling. |
| T10 |
1426-1540 |
Sentence |
denotes |
Moreover, brain mast cell (MC) activation and focal inflammation may be more prominent in ASDs than Rett syndrome. |
| T10 |
1426-1540 |
Sentence |
denotes |
Moreover, brain mast cell (MC) activation and focal inflammation may be more prominent in ASDs than Rett syndrome. |
| T11 |
1541-1722 |
Sentence |
denotes |
The flavonoid luteolin blocks microglia and MC activation, provides BDNF-like activity, reverses Rett phenotype in mouse models, and has a significant benefit in children with ASDs. |
| T11 |
1541-1722 |
Sentence |
denotes |
The flavonoid luteolin blocks microglia and MC activation, provides BDNF-like activity, reverses Rett phenotype in mouse models, and has a significant benefit in children with ASDs. |
| T12 |
1723-1835 |
Sentence |
denotes |
Appropriate formulations of luteolin or other natural molecules may be useful in the treatment of Rett syndrome. |
| T12 |
1723-1835 |
Sentence |
denotes |
Appropriate formulations of luteolin or other natural molecules may be useful in the treatment of Rett syndrome. |